News, Commentary & Events: MSOS

ADVISORSHARES PURE US CANNABIS ETF

14.37up0.25 (1.7705%)

 as of 12:49:06pm ET 05/17/2022
  • Show article details.

    U.S. Cannabis Earnings: 3 Reasons Why A Revenue Growth Trough Has Been Reached in 2022

    Benzinga - 05/03/2022

    It's no secret that the U.S. cannabis market, as broadly reflected by the industry benchmark AdvisorShares Pure US Cannabis ETF, has experienced a precipitous slowdown in growth over the past couple of quarters.

  • Show article details.

    MJ Stock Trader On SAFE Banking, CAOA And Verano Holdings - Trade To Black Podcast

    Benzinga - 05/02/2022

    In this week's Trade To Black Podcast, TDR Founder Shadd Dales and Lead Financial Writer Benjamin A. Smith interviewed popular U.S. cannabis Twitter commentator, and founder of mjstocktrader.com, MJ Stock Trader.

  • Show article details.

    AdvisorShares Pure US Cannabis ETF (MSOS) Portfolio Manager Dan Ahrens On SAFE Banking

    Benzinga - 04/25/2022

    In this week's Trade To Black Podcast, Shadd Dales interviewed AdvisorShares Pure US Cannabis ETF  Portfolio Manager Dan Ahrens, who was participating in the Benzinga Cannabis Capital Conference in Miami. Undaunted, Dan Ahrens remains as upbeat as ever about the sector's long term prospects for success.

  • Show article details.

    The AdvisorShares Pure US Cannabis ETF MSOS Reaches All-Time Low After CAOA Delay

    Benzinga - 04/20/2022

    The AdvisorShares Pure US Cannabis ETF has reached an all-time low of $17.59 after the delay of Chuck Schumer's CAOA Act. CAOA is short for Cannabis Administration and Opportunity Act. Wow.   MSOS Tumbles  The AdvisorShares Pure US Cannabis ETF trades under the symbol of MSOS.

  • Show article details.

    Options Listed for AdvisorShares ETFs

    PR Newswire - 03/10/2022

    BETHESDA, Md., March 10, 2022  AdvisorShares, a leading sponsor of actively managed exchange-traded funds, today announced that options are now listed for trading for the following ETFs: These ETFs join other AdvisorShares ETFs with options listed including the AdvisorShares Pure US Cannabis ETF (MSOS), AdvisorShares Pure Cannabis ETF (YOLO) and AdvisorShares Ranger Equity Bear ETF.

More News:

Technical Events

Technical Analysis

PROVIDED BY TRADING CENTRAL
Free commission offer applies to online purchases select ETFs in a Fidelity brokerage account. The sale of ETFs is subject to an activity assessment fee (from $0.01 to $0.03 per $1,000 of principal). ETFs are subject to market fluctuation and the risks of their underlying investments. ETFs are subject to management fees and other expenses. Unlike mutual funds, ETF shares are bought and sold at market price, which may be higher or lower than their NAV, and are not individually redeemed from the fund.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF’s prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock Inc., and its affiliates.

Fidelity receives compensation from the funds advisor or its affiliates in connection with a licensing agreement to utilize Fidelity’s active ETF methodology which may create incentives for FBS to encourage the purchase of certain ETFs.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

© 2010 Morningstar, Inc. All rights reserved. The Morningstar information contained herein (1) is proprietary to Morningstar or its affiliates; (2) may not be copied or redistributed; and (3) is not warranted to be accurate, complete, or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.

462499.7.0